Fisher, Allison L. http://orcid.org/0000-0002-9393-2442
Sangkhae, Veena
Balušíková, Kamila http://orcid.org/0000-0002-0471-5877
Palaskas, Nicolaos J. http://orcid.org/0000-0003-0783-0683
Ganz, Tomas http://orcid.org/0000-0002-2830-5469
Nemeth, Elizabeta http://orcid.org/0000-0002-3477-2397
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD096863)
U.S. Department of Health & Human Services | National Institutes of Health (T32GM065823, F31HD097931)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR0001881, UL1TR000124)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Article History
Received: 14 August 2020
Accepted: 11 June 2021
First Online: 29 June 2021
Competing interests
: T.G. and E.N. are shareholders of and scientific advisors for Intrinsic LifeSciences and Silarus Therapeutics and consultants for Ionis Pharmaceuticals, Protagonist, and Vifor. T.G. is a consultant for Akebia. All other authors declare no competing interests.